drugset / Trial / NCT00565175
Histamine H2 Antagonism as Adjuvant Therapy in Treatment Resistant Schizophrenia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the study is to investigate whether blockade of the histamine H2 receptors in the brain will have any beneficial effect on the symptoms of subjects with schizophrenia.
Timeline
- Start
- 2008-01
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Famotidine | Other / unclassified | 100 mg | Oral |